← Back
$APGE All transactions

Apogee Therapeutics, Inc.

▲ BUY
8 / 10

Conviction

$ Value

$15.0M

Shares

365,853

Price

$41

Filed

Oct 15

Why this score? (8/10)
  • Open market buy (+3)
  • Trade value >= $5.0M (+3)
  • Director (+1)
  • Not a 10b5-1 plan (+1)

Insider

Name

Shah Nimish P

Title

CIK

0001698082

Roles

Director

Transaction Details

Transaction Date

2025-10-10

Code

P

Table

Derivative

Ownership

Indirect

Equity Swap

No

Shares After

365,853

Footnotes

The exercise price is $0.00001 per share. | The Pre-Funded Warrants have no expiration date and are exercisable immediately. Notwithstanding the foregoing, Venrock Opportunities Fund, L.P. ("VOF") shall not be entitled to exercise the Pre-Funded Warrants to the extent that such exercise would cause the aggregate number of shares of Common Stock beneficially owned by VOF, its affiliates and any persons whose ownership would be aggregated with VOF's for purposes of Section 13(d) of the Securities Exchange Act to exceed 4.99% of the total number of issued and outstanding shares of Common Stock of the Issuer following such exercise. | Securities are held directly by VOF. Venrock Opportunities Management, LLC ("VO Management") is the general partner of VOF. The Reporting Person is a voting member of VO Management and expressly disclaims beneficial ownership over all shares held by VOF except to the extent of his indirect pecuniary interests therein.

Filing Info

Accession No.

0001698082-25-000003

Form Type

4

Issuer CIK

0001974640

Shah Nimish P's History

Date Ticker Type Value
2025-10-10 APGE $15.0M
2025-06-17 APGE A $0

Other Insiders at APGE (90d)

Insider Bought Sold Last
Henderson Jane
Chief Financial Officer
$652K 2026-04-16
HENDERSON MICHAEL THOMAS
Chief Executive Officer
$2.9M 2026-04-16
Dambkowski Carl
Chief Medical Officer
$828K 2026-04-01